L-Carnitine Dosing in Children
The recommended L-carnitine dosage for children is 50-100 mg/kg/day orally, with a starting dose of 50 mg/kg/day and a maximum of 3 g/day (30 mL/day), administered in divided doses every 3-4 hours, preferably during or after meals. 1
Standard Dosing Protocol
The FDA-approved dosing regimen for pediatric patients follows a clear algorithm 1:
- Starting dose: 50 mg/kg/day (equivalent to 0.5 mL/kg/day of oral solution) 1
- Therapeutic range: 50-100 mg/kg/day 1
- Maximum daily dose: 3 g/day (30 mL/day) regardless of weight 1
- Dose escalation: Increase slowly from the starting dose while monitoring tolerance and therapeutic response 1
Administration Guidelines
Doses should be divided evenly throughout the day (every 3-4 hours), preferably during or following meals, and consumed slowly to maximize gastrointestinal tolerance. 1 The oral solution may be consumed alone or dissolved in beverages or liquid food. 1
Monitoring Requirements
During treatment, periodic assessment should include 1:
- Blood chemistries
- Vital signs
- Plasma carnitine concentrations
- Overall clinical condition
Special Considerations and Cautions
Risk of Over-Supplementation
A critical caveat is that the standard 50 mg/kg/day dose can lead to over-supplementation in certain populations. In children with cystinosis and renal Fanconi syndrome, this dose resulted in elevated plasma acetylcarnitine and acylcarnitines, indicating carnitine over-supplementation despite being the "recommended" dose. 2 This suggests that plasma carnitine profiles should be monitored to prevent overdosing, particularly in patients with renal conditions. 2
Higher Doses for Specific Indications
For certain high-risk conditions, higher doses may be warranted 3:
- Valproate-induced hepatotoxicity or overdose: Intravenous L-carnitine at doses exceeding 100 mg/kg/day for acute medical emergencies 3
- Symptomatic valproate-associated hyperammonemia: 100 mg/kg/day orally, up to maximum 2 g/day 3
- Primary carnitine transporter defects: Higher pharmacologic doses may be necessary 4
Preventive Dosing in At-Risk Populations
For children on prolonged parenteral nutrition or continuous renal replacement therapy, systematic supplementation of 0.5-1 g/day should be considered for prevention of deficiency. 4 However, this applies more to adolescents approaching adult body weight.
Efficacy Considerations
Higher doses should only be administered with caution and where clinical and biochemical considerations suggest benefit. 1 Notably, in pediatric NAFLD, 50 mg/kg/day for 3 months showed no significant improvement in liver enzymes or sonographic markers, suggesting that not all conditions respond to standard carnitine dosing. 5
Side Effects
At approximately 3 g/day, carnitine can cause nausea, vomiting, abdominal cramps, diarrhea, and fishy body odor. 4 Rarer effects include muscle weakness in uremic patients and seizures in those with seizure disorders. 4